Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Clear cell renal cell carcinoma (ccRCC) is a common genitourinary cancer associated with the development of abnormal tumor angiogenesis. Although multiple anti-angiogenic therapies have been developed, responses to individual treatment are highly variable between patients. Thus, the use of one-patient clinical trials has been suggested as an alternative to standard trials. We used a microfluidic device to generate organotypic primary patient-specific blood vessel models using normal (NEnC) and tumor-associated primary CD31+ selected cells (TEnC). Our model was able to recapitulate differences in angiogenic sprouting and vessel permeability that characterize normal and tumor-associated vessels. We analyzed the expression profile of vessel models to define vascular normalization in a patient-specific manner. Using this data, we identified actionable targets to normalize TEnC vessel function to a more NEnC-like phenotype. Finally, we tested two of these drugs in our patient-specific models to determine the efficiency in restoring vessel function showing the potential of the model for single-patient clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Nintedanib, a multi-tyrosine kinase inhibitor, decreased sprout number and length, enhancing vessel permeability.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Virumbrales-Muñoz et al., 2020
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sirolimus, a specific mTOR inhibitor, exhibited lower effectiveness and only restored permeability at high doses, despite increased cell toxicity.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Virumbrales-Muñoz et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Transcriptomics revealed a pro-angiogenic phenotype in tumor-associated vessels, showing patient-specific responses.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Virumbrales-Muñoz et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“Virumbrales-Munoz and colleagues further employed a microfluidic device to generate patient-specific blood vessel models, effectively replicating phenotypic differences between ccRCC tumor-associated and normal vessels (Virumbrales-Muñoz et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Virumbrales-Muñoz et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“The results underscore the capability of microfluidic vessel models for functional drug testing, enabling personalized screening and patient stratification in ccRCC.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Virumbrales-Muñoz et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Single-Cell Transcriptome Atlas of Murine Endothelial Cells
Kalucka, J., de Rooij, L. P. M. H., Goveia, J., Rohlenova, K., Dumas, S. J., Meta, E., Conchinha, N. V., Taverna, F., Teuwen, L.-A., Veys, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.015 · Cited by 1,351
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Pauli, C., Hopkins, B. D., Prandi, D., Shaw, R., Fedrizzi, T., Sboner, A., Sailer, V., Augello, M., Puca, L., Rosati, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1154 · Cited by 937
Pusztaszeri, M. P., Seelentag, W., & Bosman, F. T. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6514.2005 · Cited by 865
Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology
Augustin, H. G., & Koh, G. Y. (2017) · Science · doi:10.1126/science.aal2379 · Cited by 762
Jonasch, E., Gao, J., & Rathmell, W. K. (2014) · BMJ · doi:10.1136/bmj.g4797 · Cited by 636
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
Lertkiatmongkol, P., Liao, D., Mei, H., Hu, Y., & Newman, P. J. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000239 · Cited by 626
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 590
Precision medicine for cancer with next-generation functional diagnostics
Friedman, A. A., Letai, A., Fisher, D. E., & Flaherty, K. T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4015 · Cited by 570
Ghadimi, B. M., Grade, M., Difilippantonio, M. J., Varma, S., Simon, R., Montagna, C., Füzesi, L., Langer, C., Becker, H., Liersch, T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.406 · Cited by 348
Perspective: The precision-oncology illusion
Prasad, V. (2016) · Nature · doi:10.1038/537s63a · Cited by 292
Altered angiogenesis and survival in human tumor‐derived endothelial cells
Bussolati, B., Deambrosis, I., Russo, S., Deregibus, M. C., & Camussi, G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0557fje · Cited by 288
The history of the angiogenic switch concept
Ribatti, D., Nico, B., Crivellato, E., Roccaro, A. M., & Vacca, A. (2007) · Leukemia · doi:10.1038/sj.leu.2404402 · Cited by 250
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
Pavesi, A., Tan, A. T., Koh, S., Chia, A., Colombo, M., Antonecchia, E., Miccolis, C., Ceccarello, E., Adriani, G., Raimondi, M. T., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89762 · Cited by 241
Huang, D., Ding, Y., Li, Y., Luo, W.-M., Zhang, Z.-F., Snider, J., VandenBeldt, K., Qian, C.-N., & Teh, B. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3722 · Cited by 240
Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma
Cowey, C. L., Amin, C., Pruthi, R. S., Wallen, E. M., Nielsen, M. E., Grigson, G., Watkins, C., Nance, K. V., Crane, J., Jalkut, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.7759 · Cited by 199
Perfused 3D angiogenic sprouting in a high-throughput in vitro platform
van Duinen, V., Zhu, D., Ramakers, C., van Zonneveld, A. J., Vulto, P., & Hankemeier, T. (2019) · Angiogenesis · doi:10.1007/s10456-018-9647-0 · Cited by 199
Precision Oncology: The Road Ahead
Senft, D., Leiserson, M. D. M., Ruppin, E., & Ronai, Z. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.08.003 · Cited by 195
Tumor angiogenesis revisited: Regulators and clinical implications
Ronca, R., Benkheil, M., Mitola, S., Struyf, S., & Liekens, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21452 · Cited by 193
Tumor angiogenesis—characteristics of tumor endothelial cells
Hida, K., Maishi, N., Torii, C., & Hida, Y. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-0957-1 · Cited by 170
Quantitative fluorescence microscopy on single capillaries: alpha-lactalbumin transport
Huxley, V. H., Curry, F. E., & Adamson, R. H. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.252.1.h188 · Cited by 161
Keisner, S. V., & Shah, S. R. (2011) · Drugs · doi:10.2165/11588960-000000000-00000 · Cited by 146
Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease
Lampugnani, M. G., Dejana, E., & Giampietro, C. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029322 · Cited by 135
LumeNEXT: A Practical Method to Pattern Luminal Structures in ECM Gels
Jiménez‐Torres, J. A., Peery, S. L., Sung, K. E., & Beebe, D. J. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500608 · Cited by 132
Self-citationAdherens junctions in endothelial cells regulate vessel maintenance and angiogenesis
Lampugnani, M. G., & Dejana, E. (2007) · Thrombosis Research · doi:10.1016/s0049-3848(07)70124-x · Cited by 109
A 3D human renal cell carcinoma-on-a-chip for the study of tumor angiogenesis
Miller, C. P., Tsuchida, C., Zheng, Y., Himmelfarb, J., & Akilesh, S. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.011 · Cited by 105
Pro-angiogenic cytokines and their role in tumor angiogenesis
Neufeld, G., & Kessler, O. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9011-5 · Cited by 103
Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma.
Rojiani, M. V., Alidina, J., Esposito, N., & Rojiani, A. M. (2010) · Europe PMC (PubMed Central) · Cited by 91
Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art
Randall, J. M., Millard, F. E., & Kurzrock, R. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9533-1 · Cited by 89
Wang, W. Y., Lin, D., Jarman, E. H., Polacheck, W. J., & Baker, B. M. (2020) · Lab on a Chip · doi:10.1039/c9lc01170f · Cited by 86
Signoretti, S., Flaifel, A., Chen, Y., & Reuter, V. E. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2259 · Cited by 80
Galambos, C., Minic, A. D., Bush, D. S., Nguyen, D. T., Dodson, B. K., Seedorf, G., & Abman, S. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159005 · Cited by 77
Quantitative assessment of angiogenesis and pericyte coverage in human cell-derived vascular sprouts
Eglinger, J., Karsjens, H., & Lammert, E. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-016-0033-2 · Cited by 66
Targeted Therapy for Cancer in the Genomic Era
Afghahi, A., & Sledge, G. W. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000135 · Cited by 55
Pak, C., Callander, N. S., Young, E. W. K., Titz, B., Kim, K., Saha, S., Chng, K., Asimakopoulos, F., Beebe, D. J., & Miyamoto, S. (2015) · Integrative Biology · doi:10.1039/c5ib00071h · Cited by 52
Self-citationHuman microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro
Zeinali, S., Bichsel, C. A., Hobi, N., Funke, M., Marti, T. M., Schmid, R. A., Guenat, O. T., & Geiser, T. (2018) · Angiogenesis · doi:10.1007/s10456-018-9631-8 · Cited by 52
Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
Keating, G. M. (2015) · Drugs · doi:10.1007/s40265-015-0418-6 · Cited by 49
Modelling of endothelial cell migration and angiogenesis in microfluidic cell culture systems
Kuzmic, N., Moore, T. A., Devadas, D., & Young, E. W. K. (2019) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-018-01111-3 · Cited by 47
Jiménez-Torres, J. A., Virumbrales-Muñoz, M., Sung, K. E., Lee, M. H., Abel, E. J., & Beebe, D. J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.026 · Cited by 46
Self-citationMorgan, M. M., Livingston, M. K., Warrick, J. W., Stanek, E. M., Alarid, E. T., Beebe, D. J., & Johnson, B. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-25461-1 · Cited by 45
Self-citationTumour vessel normalization takes centre stage
Cully, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.4 · Cited by 38
Virumbrales-Muñoz, M., Ayuso, J. M., Olave, M., Monge, R., de Miguel, D., Martínez-Lostao, L., Le Gac, S., Doblare, M., Ochoa, I., & Fernandez, L. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12049-4 · Cited by 38
Self-citationYu, K., Keskin, S. K., Meissner, M. A., Petros, F. G., Wang, X., Borregales, L. D., Gu, C., Tamboli, P., Matin, S. F., Wood, C. G., et al. (2018) · Cancer · doi:10.1002/cncr.31661 · Cited by 36
Crusz, S. M., Tang, Y. Z., Sarker, S.-J., Prevoo, W., Kiyani, I., Beltran, L., Peters, J., Sahdev, A., Bex, A., Powles, T., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0729-9 · Cited by 35
Lampugnani, M. G., Dejana, E., & Giampietro, C. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033720 · Cited by 20
Choueiri, T. K., Rini, B. I., Larkin, J., Bjarnason, G. A., Gravis, G., Gurney, H., Lee, J., Keizman, D., Haanen, J. B. A. G., Tomita, Y., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.tps4594 · Cited by 19
Research works printed but not linked: 1
- Rojiani MV, Alidina J, Esposito N. and Rojiani AM, Int J Clin Exp Pathol, 2010, 3, 775– 781. 21151391 PMC2993228
Cited by
Organs-on-a-chip models for biological research
Vunjak-Novakovic, G., Ronaldson-Bouchard, K., & Radisic, M. (2021) · Cell · doi:10.1016/j.cell.2021.08.005 · Cited by 248
“RNAsequencingofbloodvessels allowed selection of candidate drugs, ultimately leading to the testing of sirolimus and nintedanib (Virumbrales-Munoz et al., 2020).”
BackgroundA role for microfluidic systems in precision medicine
Ayuso, J. M., Virumbrales-Muñoz, M., Lang, J. M., & Beebe, D. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30384-7 · Cited by 216
Self-citationLi, W., Zhou, Z., Zhou, X., Khoo, B. L., Gunawan, R., Chin, Y. R., Zhang, L., Yi, C., Guan, X., & Yang, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202609 · Cited by 119
Organ-on-a-Chip Platforms for Drug Screening and Delivery in Tumor Cells: A Systematic Review
Gonçalves, I. M., Carvalho, V. M., Rodrigues, R. O., Pinho, D., Teixeira, S., Moita, A., Hori, T., Kaji, H., Lima, R. A., & Minas, G. M. H. (2022) · Cancers · doi:10.3390/cancers14040935 · Cited by 82
“[58] used a microfluidic device to recreate the blood vessel formation that occurs with the tumor growth.”
MethodBridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58
Metadata
- Authors
- Virumbrales-Muñoz, M., Chen, J., Ayuso, J., Lee, M., Abel, E. J., & Beebe, D. J.
- Affiliations
- Department of Pathology and Laboratory Medicine
- University of Wisconsin–Madison (US)
- Department of Urology
- University of Wisconsin System (US)
- Corresponding author
- Beebe, David J.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 20
- Issue
- 23
- Pages
- 4420-4432
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC8743028
- OpenAlex
- W3094590133
- Cited by
- 39
- References
- 51
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 4
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Lab on a Chip (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Wisconsin Carbone Cancer Center (P30 CA014520)
- NIH Clinical Center (Moonshot Grant NCI R33CA225281)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- clear cell renal cell carcinoma, patient-specific models, tumor angiogenesis, anti-angiogenic therapy, vascular normalization, CD31+ endothelial cells, microfluidics, angiogenic sprouting, vascular permeability, actionable targets
- MeSH terms
- Carcinoma, Renal Cell, Humans, Immunotherapy, Kidney Neoplasms, Neovascularization, Pathologic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.